Pregled bibliografske jedinice broj: 824420
Incidence of Anti-HBc in the Population of Croatian Blood Donors
Incidence of Anti-HBc in the Population of Croatian Blood Donors // Transfusion
Anaheim (CA), Sjedinjene Američke Države, 2007. str. 99A-99A (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 824420 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Incidence of Anti-HBc in the Population of Croatian Blood Donors
Autori
Mihaljević, Ivanka ; Lovrić, Manuela ; Babić, Ivana ; Dražić, Vesna ; Balija, Melita, Jukić, Irena
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Transfusion
/ - , 2007, 99A-99A
Skup
AABB Annual Meeting and TXPO
Mjesto i datum
Anaheim (CA), Sjedinjene Američke Države, 20.10.2007. - 23.10.2007
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Incidence of Anti-HBc; blood donors
Sažetak
The risk of HBV transmission by blood products still exists. To improve blood safety, minipool HBV-DNA and anti HBc testing are suggested in the low prevalence countries. The aim: To estimate the prevalence of anti HBc among random blood donors at CITM and to evaluate possible HBV occult infection in the group of anti HBc positive donors only. Material and methods: A total of 7561 random donors were screened for anti HBc by Ortho anti HBc “sandwich” principle test simultaneously to other mandatory tests. All positives were retested by ETI AB Corek PLUS and OCD Vitros Eci anti HBc test as well as for other HBV markers. Only anti HBc donors were tested for HBV DNA by Roche Cobas Amplicor HBV Monitor and High Pure System (Cobas TaqMan) assay. Results: The overall anti HBc prevalence was 5.42% (1.55% of new and 6.08% of repeat donors). Anti HBs was detectible in 76% of anti HBc positive donors, 0.59% (45/7561) were only anti HBc positive, and none of them was HBV DNA positive. Conclusion: Anti HBc rate among Croatian blood donors reflects the intermediate HBV endemicity. The introduction of anti HBc test in donor selection and rejection of all positives could affect blood supply. Therefore, prior decision on anti HBc as a mandatory test, the possibility of increasing blood donations and additional funding should be considered. In the meantime, introducing the most sensitive HBsAg ULTRA tests in donor testing would be appropriate.
Izvorni jezik
Engleski
Znanstvena područja
Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Ustanove:
Hrvatski zavod za transfuzijsku medicinu